Xingbing Wang

5PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMineral processing/beneficiationToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 03, 2026
Non-gene-edited, CD19-targeted, allogeneic CAR-T cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia: an open-label, single-arm phase 1 study.

|May 30, 2026
CLN7 suppression induces apoptosis via mTOR-regulated and chaperone-mediated autophagy in myeloid leukemia cells.

|Jul 01, 2024
Lysosomal cation channel TRPML1 suppression sensitizes acute myeloid leukemia cells to chemotherapeutics by inhibiting autophagy.

Meifang Dai, Bingqian Lin, Hao Li

|Apr 26, 2024
Structural insights into the calcium-coupled zinc export of human ZnT1.

Chunqiao Sun, Bangguo He, Yongxiang Gao

|Aug 01, 2022
Lysosomal K+ channel TMEM175 promotes apoptosis and aggravates symptoms of Parkinson's disease.

Lili Qu, Bingqian Lin, Wenping Zeng

Pageof 1

Frequent Collaborators

3 joint publications

Chunlei Cang

2 joint publications

Lili Qu

2 joint publications

Miaomiao Wu

1 joint publications

Bingqian Lin